Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 91

1.

Peroxiredoxins and tropomyosins as plasma biomarkers for lung cancer and asbestos exposure.

Rostila A, Puustinen A, Toljamo T, Vuopala K, Lindström I, Nyman TA, Oksa P, Vehmas T, Anttila SL.

Lung Cancer. 2012 Aug;77(2):450-9. doi: 10.1016/j.lungcan.2012.03.024. Epub 2012 Apr 24.

PMID:
22537621
2.

High association of peroxiredoxins with lung cancer.

Soini Y, Kinnula VL.

Lung Cancer. 2012 Nov;78(2):167. doi: 10.1016/j.lungcan.2012.08.013. Epub 2012 Sep 14. No abstract available.

PMID:
22981900
3.

p53 protein, EGF receptor, and anti-p53 antibodies in serum from patients with occupationally derived lung cancer.

Schneider J, Presek P, Braun A, Bauer P, Konietzko N, Wiesner B, Woitowitz HJ.

Br J Cancer. 1999 Aug;80(12):1987-94.

4.

p16INK4A inactivation mechanisms in non-small-cell lung cancer patients occupationally exposed to asbestos.

Andujar P, Wang J, Descatha A, Galateau-Sallé F, Abd-Alsamad I, Billon-Galland MA, Blons H, Clin B, Danel C, Housset B, Laurent-Puig P, Le Pimpec-Barthes F, Letourneux M, Monnet I, Régnard JF, Renier A, Zucman-Rossi J, Pairon JC, Jaurand MC.

Lung Cancer. 2010 Jan;67(1):23-30. doi: 10.1016/j.lungcan.2009.03.018. Epub .

PMID:
19375815
5.
6.

Malignant and non-malignant asbestos-related pleural and lung disease: 10-year follow-up study.

Cvitanović S, Znaor L, Konsa T, Ivancević Z, Perić I, Erceg M, Vujović M, Vuković J, Beg-Zec Z.

Croat Med J. 2003 Oct;44(5):618-25.

7.

Chemokine (C-C motif) ligand 3 detection in the serum of persons exposed to asbestos: A patient-based study.

Xu J, Alexander DB, Iigo M, Hamano H, Takahashi S, Yokoyama T, Kato M, Usami I, Tokuyama T, Tsutsumi M, Tamura M, Oguri T, Niimi A, Hayashi Y, Yokoyama Y, Tonegawa K, Fukamachi K, Futakuchi M, Sakai Y, Suzui M, Kamijima M, Hisanaga N, Omori T, Nakae D, Hirose A, Kanno J, Tsuda H.

Cancer Sci. 2015 Jul;106(7):825-32. doi: 10.1111/cas.12687. Epub 2015 Jun 5.

8.

k-ras mutation and occupational asbestos exposure in lung adenocarcinoma: asbestos-related cancer without asbestosis.

Nelson HH, Christiani DC, Wiencke JK, Mark EJ, Wain JC, Kelsey KT.

Cancer Res. 1999 Sep 15;59(18):4570-3.

9.

Clinical study of asbestos-related lung cancer in Japan with special reference to occupational history.

Kishimoto T, Gemba K, Fujimoto N, Onishi K, Usami I, Mizuhashi K, Kimura K.

Cancer Sci. 2010 May;101(5):1194-8. doi: 10.1111/j.1349-7006.2010.01509.x. Epub 2010 Jan 22.

10.

[Medical surveillance of previously asbestos-exposed workers: report of a case of lung cancer with high level of serum mesothelin].

Guglielmi G, Ciberti A, Foddis R, Ambrosino N, Chella A, Gattini V, Buselli R, Ottenga F, Cristaudo A.

G Ital Med Lav Ergon. 2007 Jul-Sep;29(3 Suppl):345-6. Italian.

PMID:
18409717
11.

Association between asbestos exposure, cigarette smoking, myeloperoxidase (MPO) genotypes, and lung cancer risk.

Schabath MB, Spitz MR, Delclos GL, Gunn GB, Whitehead LW, Wu X.

Am J Ind Med. 2002 Jul;42(1):29-37.

PMID:
12111688
12.

The effect of asbestosis on lung cancer risk beyond the dose related effect of asbestos alone.

Reid A, de Klerk N, Ambrosini GL, Olsen N, Pang SC, Berry G, Musk AW.

Occup Environ Med. 2005 Dec;62(12):885-9.

13.

Assessment of biomarkers in asbestos-exposed workers as indicators of cancer risk.

Amati M, Tomasetti M, Mariotti L, Tarquini LM, Valentino M, Santarelli L.

Mutat Res. 2008 Aug-Sep;655(1-2):52-8. doi: 10.1016/j.mrgentox.2008.06.011.

PMID:
18638565
14.

Plasma proteomic profiling: search for lung cancer diagnostic and early detection markers.

Ali IU, Xiao Z, Malone W, Smith M, Conrads TP, Veenstra TD, Greenwald P, Luke BT, McLarty JW.

Oncol Rep. 2006 May;15(5):1367-72.

PMID:
16596212
15.

Asbestos exposure according to different exposure indices among Finnish lung cancer patients.

Vilkman S, Lahdensuo A, Mattila J, Tossavainen A, Tuomi T.

Int Arch Occup Environ Health. 1993;65(4):269-74.

PMID:
8144239
16.

Copy number gains on 5p15, 6p11-q11, 7p12, and 8q24 are rare in sputum cells of individuals at high risk of lung cancer.

Kettunen E, Salmenkivi K, Vuopala K, Toljamo T, Kuosma E, Norppa H, Knuutila S, Kaleva S, Huuskonen MS, Anttila S.

Lung Cancer. 2006 Nov;54(2):169-76. Epub 2006 Aug 28.

PMID:
16935392
17.

Augmented expression of peroxiredoxin I in lung cancer.

Chang JW, Jeon HB, Lee JH, Yoo JS, Chun JS, Kim JH, Yoo YJ.

Biochem Biophys Res Commun. 2001 Nov 30;289(2):507-12.

PMID:
11716502
18.

Synchronous diffuse malignant mesothelioma and carcinomas in asbestos-exposed individuals.

Attanoos RL, Thomas DH, Gibbs AR.

Histopathology. 2003 Oct;43(4):387-92.

PMID:
14511258
19.

Computed tomography screening for lung cancer in asbestos-exposed workers.

Tiitola M, Kivisaari L, Huuskonen MS, Mattson K, Koskinen H, Lehtola H, Zitting A, Vehmas T.

Lung Cancer. 2002 Jan;35(1):17-22.

PMID:
11750708
20.

ADAM28: a potential oncogene involved in asbestos-related lung adenocarcinomas.

Wright CM, Larsen JE, Hayward NK, Martins MU, Tan ME, Davidson MR, Savarimuthu SM, McLachlan RE, Passmore LH, Windsor MN, Clarke BE, Duhig EE, Yang IA, Bowman RV, Fong KM.

Genes Chromosomes Cancer. 2010 Aug;49(8):688-98. doi: 10.1002/gcc.20779.

PMID:
20544843
Items per page

Supplemental Content

Write to the Help Desk